[News in neurology 2013]

Area of Science:

• Neurology
• Pharmacology
• Medical Research

Background:

• Epilepsy treatment options are expanding with new drug approvals.
• Advancements in anticoagulation improve stroke prevention in atrial fibrillation.
• Deep brain stimulation (DBS) is a viable treatment for advanced Parkinson's disease.

Purpose of the Study:

• To review recent therapeutic advancements across various neurological conditions.
• To assess the efficacy and potential side effects of novel treatments.
• To provide an overview of current medical strategies for neurological disorders.

Main Methods:

• Literature review of recent studies and clinical trials.
• Analysis of approved medications and therapeutic interventions.
• Synthesis of evidence on treatment outcomes and patient benefits.

Main Results:

• Perampanel approved for pharmaco-resistant epilepsy (2013).
• New anticoagulants outperform vitamin K antagonists for stroke prevention in atrial fibrillation.
• DBS is effective for advanced Parkinson's disease.
• Intranasal ketamine shows promise for severe migraine aura.
• Topical capsaicin benefits post-herpetic neuralgia.
• Statins may negatively impact cognitive function in Alzheimer's disease.
• Oral immunomodifying treatments slow cerebral atrophy in multiple sclerosis.

Conclusions:

• Recent pharmaceutical and therapeutic innovations offer improved management for several neurological conditions.
• Continued research is vital to optimize treatments and understand long-term effects.
• Personalized therapeutic approaches are crucial for conditions like epilepsy, Parkinson's, and multiple sclerosis.